Yuma welcomes new CMIO

Yuma Regional Medical Center (YRMC) welcomes Robert D. Budman, MD, MBA, as CMIO. In this role, he will provide physician leadership in the optimization of YRMCCare, Yuma Regional’s EHR. 

“I am pleased that Dr. Budman has joined our leadership team,” said Gene Shaw, VP of IT at the Zuma, Ariz.-based YRMC. “His knowledge and understanding of how to utilize technology, such as the EHR, to increase patient safety and quality will serve as a tremendous asset to our hospital and community.”

Budman most recently served as the director of clinical content at Catholic Health East in Newtown Square, Pa., where he improved patient care by creating new electronic communication methods based on the most current national standards and by streamlining care standards through the implementation of hundreds of new evidence-based order sets.

Budman completed his medical doctorate at the Medical University of South Carolina and holds an MBA in healthcare management as well as a certificate in healthcare informatics from the University of Phoenix.  

One of Budman’s goals as CMIO is to optimize the use of YRMCCare to better meet the growing needs of the community, by improving physicians’ use of EHRs.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.